Desjardins Capital — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Puzzle Medical develops a heart failure treatment device designed to improve heart and kidney function through 4Fr axillary access, allowing patient ambulation and providing up to seven days of support.
HardwareHealthtechMedical DevicesMontreal
FRANCOIS TRUDEAU(Executive Officer, Director)JADE DOUCET-MARTINEAU(Executive Officer, Director)Jade Doucet-Martineau(Co-founder & CEO, Board Director)François Trudeau(Co-founder & CTO, Board Director)Philippe Généreux(Co-founder (Phase 2), Chief Medical Officer & Board Observer)Maxime Rochon(Co-founder (Phase 2) & VP Clinical, Regulatory and Quality)
Co-investorsBroadview VenturesLumira VenturesAjax HealthBoreal VenturesCathexis VenturesFront Row Ventures+1 more
Optable provides a cloud-based platform for identity, audience, and data collaboration that lets publishers, media companies, and advertisers own, enrich, and monetize their first-party data while maintaining privacy.
AdTechData & InfrastructureMarketing TechLos Angeles, US
Yves PoiréVlad StesinBosko MilekicWilliam Glasgow Phillips(Executive Officer, Director)
Co-investorsBrightspark VenturesasterXDeloitte VenturesHearst Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.